Virtual event on Friday, March 1, 2024 at 10:00 AM ET Event will feature GBS experts Lisa Butler of the GBS|CIDP Foundation International, Hugh Willison, MBBS, PhD, Professor Emeritus of Neurology of.
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon s Novel Therapeutic Approach tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Annexon To Host Virtual R&D Day On Guillain-Barré Syndrome, Focusing On Its Serious Unmet Need And Annexon S Novel Therapeutic Approach menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
CONSHOHOCKEN, Pa., Dec. 21, 2020 /PRNewswire/ Confusion regarding the COVID-19 vaccination is growing among patients and caregivers coping with Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy. The GBS|CIDP Foundation International provides up-to-date resources, publications and statements that are vetted through the Foundation s Global Medical Advisory Board (GMAB), and key opinion leaders from the GBS|CIDP Medical Community worldwide. In response to a recent public statement made by Dr. A.S. Fauci, Director of NIAID, NIH, regarding the COVID-19 vaccine as it pertains to the GBS community, and to further clarify COVID-19 vaccine confusion among patients & caregivers, the following open letter to Dr. A.S. Fauci, has been authored as referenced.